73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Minimizing immunotherapy's potentially harmful side effects

Minimizing immunotherapy's potentially harmful side effects

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainRecent advances in treating multiple myeloma, the second most common blood cancer, and other blood mali

Minimizing immunotherapy's potentially harmful side effects

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainRecent advances in treating multiple myeloma, the second most common blood cancer, and other blood mali
Cancer patients who don't respond to immunotherapy may lack crucial immune cells

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D
Lung nodule program provides benefits to patients ineligible for lung cancer screening

Lung nodule program provides benefits to patients ineligible for lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not

Lung nodule program provides benefits to patients ineligible for lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not
Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

byUniversity of BaselSports therapy to combat side effects: Fiona Streckmann with a patient during a neurological examination. A tuning fork is used to test vibration sensation, which can be alt

Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

byUniversity of BaselSports therapy to combat side effects: Fiona Streckmann with a patient during a neurological examination. A tuning fork is used to test vibration sensation, which can be alt
Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer TreatmentUnique Treatment Approaches for Early-Stage and Locally Advanced Lung CancersByJennifer WelshUpdated on October 10, 2023Medically review

Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer TreatmentUnique Treatment Approaches for Early-Stage and Locally Advanced Lung CancersByJennifer WelshUpdated on October 10, 2023Medically review
Patient step counts predict lung cancer treatment outcomes, study finds

Patient step counts predict lung cancer treatment outcomes, study finds

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainNumerous studies have shown that monitoring physical activity promotes better health—from reducing body mass index to watching f

Patient step counts predict lung cancer treatment outcomes, study finds

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainNumerous studies have shown that monitoring physical activity promotes better health—from reducing body mass index to watching f
Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi
One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i
Racial disparities in lung cancer start with research

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl
Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in
Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect
Men often confused about prostate cancer screening, survey shows

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak